Pharma Surge
Pharma Surge
Intelligence Layer
🇫🇷·Jun 11Industry

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress

Publisher

C
Cellectis

France

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Cellectis
Region
France
Scope
Industry
Published
June 11, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on cellectis.com

Leave the platform to read the original full article on the publisher site.

Source: Cellectis

Scope: Industry

Open original article
Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress | Pharma Surge